AlloVir, Inc. (ALVR)

NASDAQ: ALVR · IEX Real-Time Price · USD
0.751
+0.009 (1.24%)
Apr 19, 2024, 2:05 PM EDT - Market open
1.24%
Market Cap 85.70M
Revenue (ttm) n/a
Net Income (ttm) -190.42M
Shares Out 114.06M
EPS (ttm) -1.83
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 180,836
Open 0.750
Previous Close 0.742
Day's Range 0.746 - 0.760
52-Week Range 0.623 - 6.120
Beta 0.85
Analysts Hold
Price Target 5.88 (+682.64%)
Earnings Date May 2, 2024

About ALVR

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenz... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Jul 30, 2020
Employees 112
Stock Exchange NASDAQ
Ticker Symbol ALVR
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for ALVR stock is "Hold." The 12-month stock price forecast is $5.88, which is an increase of 682.64% from the latest price.

Price Target
$5.88
(682.64% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Shareholders of AlloVir, Inc. Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR

NEW YORK, NY / ACCESSWIRE / March 19, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

4 weeks ago - Accesswire

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVR

NEW YORK , March 19, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR). The class action, filed ...

4 weeks ago - PRNewsWire

AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ALVR

NEW YORK, NY / ACCESSWIRE / March 19, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

4 weeks ago - Accesswire

Levi & Korsinsky Notifies Shareholders of AlloVir, Inc.(ALVR) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, NY / ACCESSWIRE / March 19, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

4 weeks ago - Accesswire

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the...

4 weeks ago - Accesswire

AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR

NEW YORK, NY / ACCESSWIRE / March 18, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

4 weeks ago - Accesswire

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVR

NEW YORK, NY / ACCESSWIRE / March 18, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

4 weeks ago - Accesswire

Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / March 17, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

4 weeks ago - Accesswire

FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the...

4 weeks ago - Accesswire

Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR

NEW YORK, NY / ACCESSWIRE / March 17, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

4 weeks ago - Accesswire

ALVR DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALVR

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc. (NASDAQ: ALVR) between March 22, 2022 and December 21, 2023, both d...

4 weeks ago - Business Wire

Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR

NEW YORK, NY / ACCESSWIRE / March 17, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

4 weeks ago - Accesswire

Levi & Korsinsky Reminds AlloVir, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR

NEW YORK, NY / ACCESSWIRE / March 17, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

4 weeks ago - Accesswire

AlloVir, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR

NEW YORK, NY / ACCESSWIRE / March 16, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

4 weeks ago - Accesswire

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of AlloVir, Inc.(ALVR) Shareholders

NEW YORK, NY / ACCESSWIRE / March 15, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

4 weeks ago - Accesswire

ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , March 15, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR) of a class action securities lawsuit. CLASS DEFINITION: ...

5 weeks ago - PRNewsWire

March 19, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - ALVR

NEW YORK, NY / ACCESSWIRE / March 15, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

5 weeks ago - Accesswire

Contact Levi & Korsinsky by March 19, 2024 Deadline to Join Class Action Against AlloVir, Inc. (ALVR)

NEW YORK, NY / ACCESSWIRE / March 14, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

5 weeks ago - Accesswire

Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law Firm

NEW YORK , March 14, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of AlloVir, Inc.. Shareholders who purchased shares of ALVR during the class period listed are ...

5 weeks ago - PRNewsWire

Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline 0 ALVR

NEW YORK, NY / ACCESSWIRE / March 14, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

5 weeks ago - Accesswire

Contact Levi & Korsinsky by March 19, 2024 Deadline to Join Class Action Against AlloVir, Inc.(ALVR)

NEW YORK, NY / ACCESSWIRE / March 14, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

5 weeks ago - Accesswire

Shareholders that lost money on AlloVir, Inc. (ALVR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

NEW YORK, NY / ACCESSWIRE / March 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

5 weeks ago - Accesswire

AlloVir, Inc. Class Action: Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR

NEW YORK, NY / ACCESSWIRE / March 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

5 weeks ago - Accesswire

Shareholders that lost money on AlloVir, Inc. (ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR

NEW YORK, NY / ACCESSWIRE / March 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

5 weeks ago - Accesswire

Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ALVR

NEW YORK, NY / ACCESSWIRE / March 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follo...

5 weeks ago - Accesswire